Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
assay | laboratory test for a particular substance or activity | Request the confirmatory assay on the retained specimen. | Plan | Diagnostic procedures and specimen handling |
assay-specific target | target defined using a particular measurement method | The assay-specific target was checked before comparing results reported by two laboratories. | Assessment | Medication response, exposure and reconciliation |
assay confirmation | additional laboratory verification of the measured result | Contact the laboratory to request assay confirmation of the unexpected value. | Plan | Drug levels - verification and documentation |
assay cross-reactivity | measurement response to substances other than the intended analyte | The laboratory was asked whether assay cross-reactivity might affect the immunoassay result. | Assessment | Drug concentrations, exposure and assay interpretation |
assay imprecision | random variation on repeated measurement of the same material | The difference between near-identical repeat results may reflect assay imprecision. | Assessment | Drug concentrations, exposure and assay interpretation |
assay interference | another substance or condition alters the measurement | The laboratory appended a comment about possible assay interference. | Objective | Drug levels - analyte, specimen and reporting |
assay method | technique used to obtain a reported concentration | The assay method is specified on the transplant laboratory report. | Objective | Drug levels - analyte, specimen and reporting |
| units attached to the measured laboratory value | Verify the assay units before comparing the outside result. | Plan | Drug levels - verification and documentation | |
assay variability | variation attributable to measurement methods or performance | The small difference is being reviewed in light of assay variability. | Assessment | Medication exposure, response and adverse-effect reasoning |
HIV differentiation assay | supplemental test used to distinguish HIV-1 from HIV-2 antibodies | The HIV differentiation assay was reviewed as part of the reported testing sequence. | Objective | Molecular testing, serology and culture findings |
| test that uses antibody recognition | The outside concentration was measured by immunoassay. | Objective | Drug levels - analyte, specimen and reporting | |
lupus anticoagulant assay | phospholipid-dependent testing for a circulating inhibitor | The lupus anticoagulant assay was reviewed with the current anticoagulant exposure. | Objective | Coagulation, antibodies and hemostasis studies |
platelet function assay | test of how well platelets respond under defined conditions | The platelet function assay was interpreted with the platelet count. | Objective | Coagulation, antibodies and hemostasis studies |
activated protein C resistance | reduced anticoagulant response to activated protein C in a functional assay | Activated protein C resistance was reported with a comment on assay interference. | Objective | Coagulation, antibodies and hemostasis studies |
analyte | substance the assay measures | The analyte on the outside report is total phenytoin. | Objective | Drug levels - analyte, specimen and reporting |
anti-Xa activity | assay of factor Xa inhibition with assay-specific calibration | The report identifies heparin-calibrated anti-Xa activity. | Objective | Hematology, coagulation and transfusion observations |
antigen | substance detected by a specified immunologic assay | The viral antigen test was collected on day two of symptoms. | Objective | Microbiology and specimen interpretation |
below-quantitation result | analyte is below the assay's stated range for reliable quantification | The below-quantitation result was preserved with the laboratory's qualifier and units. | Assessment | Medication response, exposure and reconciliation |
beta-D-glucan | fungal cell-wall component measured by a nonspecies-specific assay | Beta-D-glucan was reported with the laboratory cutoff and exposure history. | Objective | Molecular testing, serology and culture findings |
| material of known value used to establish assay response | The laboratory repeated analysis after checking the calibrator. | Objective | Drug levels - analyte, specimen and reporting | |
carbamazepine epoxide | active carbamazepine metabolite measured separately by some assays | The carbamazepine epoxide result is listed separately from the parent level. | Objective | Drug levels - named analytes and exposure reports |
chromatography | separation technique used before detection in some assays | The assay used liquid chromatography before detection. | Objective | Drug levels - analyte, specimen and reporting |
clot lysis | breakdown of a formed clot during a hemostasis assay | Clot lysis was quantified over the specified observation period. | Objective | Coagulation, antibodies and hemostasis studies |
cross-reactant | substance other than the intended analyte recognized by an assay | The laboratory identified a possible cross-reactant in the immunoassay. | Objective | Drug levels - analyte, specimen and reporting |
cycle threshold | PCR cycle at which signal passes the assay threshold | The report lists a cycle threshold with the assay platform. | Objective | Microbiology and specimen interpretation |